As attached

Date: July 30, 2026 The General Manager – Lis(cid:415)ng Compliance BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001. Scrip Code: 519242 Subject: Outcome of the Proceedings of the Extra-Ordinary General Mee(cid:415)ng of the Company held on July 30, 2026 Dear Sir/Madam, Pursuant to Regula(cid:415)on 30 read with Para A of Part A of Schedule III of the Securi(cid:415)es and Exchange Board of India (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015, we hereby submit the enclosed Outcome of the Proceedings of the Extra-Ordinary General Mee(cid:415)ng ("EGM") of the Members of Sarda Proteins Limited, held on Thursday, July 30, 2026, through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM"). The Mee(cid:415)ng commenced at 11:00 A.M. (IST) and concluded at 11:21 A.M. (IST). The vo(cid:415)ng results of the businesses transacted at the aforesaid EGM, together with the Consolidated Scru(cid:415)nizer's Report, shall be submi(cid:425)ed separately within the prescribed (cid:415)melines under Regula(cid:415)on 44 of the SEBI (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015. Kindly take the above informa(cid:415)on on your records. Thanking you. Yours faithfully, For & on behalf of the Board of Directors of SARDA PROTEINS LIMITED SHIRISH DHIRAJLAL SAVALIYA Managing Director DIN: 08721554 Encl.: Outcome of the Proceedings of the Extra-Ordinary General Mee(cid:415)ng. OUTCOME OF THE PROCEEDINGS OF THE EXTRA-ORDINARY GENERAL MEETING OF THE COMPANY Pursuant to Regula(cid:415)on 30 read with Para A of Part A of Schedule III of the Securi(cid:415)es and Exchange Board of India (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015 ("SEBI Lis(cid:415)ng Regula(cid:415)ons"), we hereby inform that the Extra-Ordinary General Mee(cid:415)ng ("EGM") of the Members of Sarda Proteins Limited ("the Company") was held on Thursday, July 30, 2026 through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM") in accordance with the applicable provisions of the Companies Act, 2013, the Rules made thereunder and the Circulars issued by the Ministry of Corporate Affairs and the Securi(cid:415)es and Exchange Board of India. The Mee(cid:415)ng commenced at 11:00 A.M. (IST). At the outset, CS Dharmik Solanki, Advisor to the Company, welcomed the Members, Directors, Auditors, Scru(cid:415)nizer and other par(cid:415)cipants a(cid:425)ending the Mee(cid:415)ng through VC/OAVM. He informed the Members that the requisite quorum was present throughout the Mee(cid:415)ng and accordingly declared the Mee(cid:415)ng duly cons(cid:415)tuted. Therea(cid:332)er, the Members were informed that Mr. Yagnik Arvindbhai Satasiya had been appointed as the Chairperson of the Mee(cid:415)ng. The Chairperson took the Chair and conducted the proceedings of the Mee(cid:415)ng. With the permission of the Members present, the No(cid:415)ce convening the Extra-Ordinary General Mee(cid:415)ng together with the Explanatory Statement annexed thereto was taken as read, as the same had already been circulated electronically to all the Members within the prescribed statutory period. The Members were informed that the Company had provided the facility of Remote e- Vo(cid:415)ng to all eligible Members in respect of all the resolu(cid:415)ons contained in the No(cid:415)ce of the EGM. The e-Vo(cid:415)ng facility was also made available during the Mee(cid:415)ng to those Members who had not cast their votes through Remote e-Vo(cid:415)ng. The e-Vo(cid:415)ng facility remained open during the Mee(cid:415)ng and for fi(cid:332)een (15) minutes a(cid:332)er the conclusion thereof. Therea(cid:332)er, the following businesses as set out in the No(cid:415)ce convening the Extra-Ordinary General Mee(cid:415)ng were transacted: Item No. 1: Approval for increase in the Authorised Share Capital of the Company from ₹13,00,00,000 (Rupees Thirteen Crore Only) to ₹1,00,00,00,000 (Rupees One Hundred Crore Only) and consequen(cid:415)al altera(cid:415)on of Clause V of the Memorandum of Associa(cid:415)on of the Company. Item No. 2: Approval for altera(cid:415)on of the Main Object Clause of the Memorandum of Associa(cid:415)on of the Company to align the objects of the Company with its proposed future business ac(cid:415)vi(cid:415)es and expansion plans. Item No.3: Approval for regularisa(cid:415)on of Mr. Gunvantray Jayan(cid:415)lal Zaladi (DIN: 11253353) as a Non-Execu(cid:415)ve, Non-Independent Director of the Company. Item No. 4: Approval for regularisa(cid:415)on of Mr. Shivam Gunvantray Zaladi (DIN: 11251860) as a Non-Execu(cid:415)ve, Non-Independent Director of the Company. Item No. 5: Approval for appointment of Mr. Shirish Dhirajlal Savaliya (DIN: 08721554) as the Managing Director of the Company. Item No. 6: Approval for regularisa(cid:415)on and appointment of Mr. Yagnik Arvindbhai Satasiya as the Non-Execu(cid:415)ve Chairperson of the Company. Item No. 7: Approval for change of the name of the Company from "Sarda Proteins Limited" to "Fresita Proteins Limited" together with the consequen(cid:415)al altera(cid:415)on of the Memorandum of Associa(cid:415)on and Ar(cid:415)cles of Associa(cid:415)on of the Company. While taking up the aforesaid item, the Members were informed that the Company had already received the Name Availability Approval from the Central Registra(cid:415)on Centre (CRC), Ministry of Corporate Affairs, for the proposed name "Fresita Proteins Limited". Further, the Company had obtained a Cer(cid:415)ficate issued by the Statutory Chartered Accountant cer(cid:415)fying compliance with the requirements of Regula(cid:415)on 45 of the SEBI (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015 in rela(cid:415)on to the proposed change of name. The said Cer(cid:415)ficate was placed before the Members and taken on record. The Members therea(cid:332)er considered the proposal for change of name, subject to receipt of the necessary statutory and regulatory approvals. Item No. 8: Approval for appointment of the Statutory Auditor to fill the casual vacancy caused in the office of the Statutory Auditor of the Company. Item No. 9: Approval for appointment of the Statutory Auditors of the Company for a first term of five consecu(cid:415)ve years commencing from April 1, 2026 and ending on March 31, 2031. Item No. 10: Approval for appointment of Ms. Minal Surendra Jain (DIN: 11822395) as an Independent Woman Director of the Company for the term specified in the No(cid:415)ce convening the Mee(cid:415)ng. The Members were further informed that CS Dipika Soni, Prac(cid:415)cing Company Secretary, had been appointed as the Scru(cid:415)nizer to scru(cid:415)nize the Remote e-Vo(cid:415)ng process and the e-Vo(cid:415)ng conducted during the Mee(cid:415)ng in a fair and transparent manner. It was also informed that the Consolidated Scru(cid:415)nizer's Report on the vo(cid:415)ng results would be submi(cid:425)ed to the Chairperson upon comple(cid:415)on of the scru(cid:415)ny process. The vo(cid:415)ng results along with the Scru(cid:415)nizer's Report shall be disseminated to BSE Limited, uploaded on the website of the Company and the website of the e-Vo(cid:415)ng agency within the (cid:415)melines prescribed under the Companies Act, 2013 and the SEBI Lis(cid:415)ng Regula(cid:415)ons. The Advisor thanked all the Members for their ac(cid:415)ve par(cid:415)cipa(cid:415)on, con(cid:415)nued confidence and support extended to the Company. There being no other business to transact, the Mee(cid:415)ng concluded at 11:21 A.M. (IST) with a vote of thanks to the Chair.